Trial
NCT00822926
Subcutaneous Botulinum Toxin for Cutaneous Allodynia - Enriched Responder Trial
UnknownTERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
Stanford University
Collaborators
—
Condition
Pain
Intervention
Botulinum Toxin Type A
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-08-15